Calamos Advisors LLC Purchases New Position in BrightSpring Health Services, Inc. $BTSG

Calamos Advisors LLC purchased a new stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG) during the third quarter, HoldingsChannel.com reports. The fund purchased 22,963 shares of the company’s stock, valued at approximately $1,303,000.

A number of other institutional investors also recently modified their holdings of the company. The Manufacturers Life Insurance Company acquired a new stake in shares of BrightSpring Health Services in the second quarter worth $239,377,000. Bank of America Corp DE bought a new stake in shares of BrightSpring Health Services during the 2nd quarter worth $127,475,000. Bank of New York Mellon Corp acquired a new position in BrightSpring Health Services in the 2nd quarter valued at $118,162,000. Arrowstreet Capital Limited Partnership grew its stake in BrightSpring Health Services by 109.7% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,370,440 shares of the company’s stock valued at $58,394,000 after buying an additional 716,949 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its stake in BrightSpring Health Services by 236.1% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 860,134 shares of the company’s stock valued at $36,151,000 after buying an additional 604,232 shares during the last quarter.

BrightSpring Health Services Stock Up 3.0%

Shares of BTSG stock opened at $69.15 on Tuesday. BrightSpring Health Services, Inc. has a 12 month low of $30.64 and a 12 month high of $73.75. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.99. The firm has a market cap of $13.76 billion, a PE ratio of 37.38, a price-to-earnings-growth ratio of 0.79 and a beta of 1.77. The stock has a 50 day moving average of $60.96 and a 200-day moving average of $55.41.

BrightSpring Health Services (NASDAQ:BTSG) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.07. BrightSpring Health Services had a net margin of 2.69% and a return on equity of 18.56%. The business had revenue of $4.21 billion for the quarter, compared to the consensus estimate of $3.88 billion. The company’s revenue was up 26.4% on a year-over-year basis. On average, equities analysts predict that BrightSpring Health Services, Inc. will post 1.70 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently commented on BTSG. Wells Fargo & Company lifted their target price on shares of BrightSpring Health Services from $78.00 to $82.00 and gave the stock an “overweight” rating in a report on Monday, November 2nd. Morgan Stanley upped their price target on shares of BrightSpring Health Services from $71.00 to $80.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Wall Street Zen raised BrightSpring Health Services from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 31st. TD Cowen raised their price target on BrightSpring Health Services from $81.00 to $84.00 and gave the company a “buy” rating in a research report on Monday, November 2nd. Finally, Leerink Partners lifted their price objective on BrightSpring Health Services from $72.00 to $92.00 and gave the stock an “outperform” rating in a research note on Monday, November 2nd. Two equities research analysts have rated the stock with a Strong Buy rating and seventeen have issued a Buy rating to the stock. According to MarketBeat.com, BrightSpring Health Services currently has a consensus rating of “Buy” and an average target price of $77.81.

BrightSpring Health Services Profile

BrightSpring Health Services is a provider of home- and community-based health services in the United States. The company supports people with complex health needs, including individuals with intellectual and developmental disabilities, behavioral health conditions, and chronic or age-related illnesses.

Its services include home health and hospice care, behavioral health and rehabilitation, residential and community-based support, and pharmacy services. BrightSpring’s pharmacy operations provide prescription dispensing and related services to people receiving care in homes, community settings, and long-term care facilities.

Headquartered in Louisville, Kentucky, BrightSpring operates across the United States.